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Abstract Mass spectrometric analysis identi¢ed a 49 kDa
antigen from Toxoplasma gondii as protein disul¢de isomerase
(PDI). This antigen is generally recognized by IgA in tears of
healthy humans. We determined the complete open reading
frame and expressed PDI recombinantly. Recombinant PDI
was recognized by IgA in human tears known to contain anti-
bodies speci¢c for the 49 kDa antigen. High expression level and
similarity to other protozoan PDIs suggest that T. gondii PDI
might be a suitable target for recently described anti-protozoan
drugs. PDI-speci¢c antibodies clearly constitute part of the mu-
cosal antibody repertoire possibly involved in defence against
parasites. ) 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Toxoplasma gondii is a protozoan parasite that has the re-
markable ability to infect a wide variety of mammalian species
and birds [1]. In humans, infection can cause serious compli-
cations like systemic, ocular and congenital toxoplasmosis
[1,2].
To prevent toxoplasmosis, several immunological mecha-
nisms are available of which the mucosal system forms the
¢rst line of defence. In this context, our recent ¢nding that
80% of individuals have anti-T. gondii IgA antibodies in their
tears is of interest [3]. The presence of these IgAs was inde-
pendent of systemic immunity against T. gondii and anti-49
kDa IgA antibodies in human tears could be pre-absorbed by
incubation with intact, live T. gondii tachyzoites, indicating
that the antigen is present on the exterior of the parasite [3].
Tears are continuously secreted by the lacrimal gland, an ef-
fector organ of the common mucosal immune system, and
contain high concentrations of IgA antibodies [4]. Besides
constituting the continuous immunologic barrier of the ocular
surface and conjunctiva against pathogens during the day,
tears are continuously drained by the nasolacrimal ducts, im-
plying that tear IgA antibodies protect epithelial layers of
these ducts, the upper respiratory tract, throat and esophagus.
These anti-toxoplasma antibodies might be part of the con-
tinuous mucosal defence against protozoan parasites, either as
a natural adaptation to co-existence with protozoan parasites
or due to regular mucosal contact with parasitic antigens.
Interestingly, a 49 kDa antigen was prominently recognized
by IgA antibodies in tears [3]. Identi¢cation of this antigen
will give indications whether these antibodies are actively in-
volved in defence against T. gondii, and whether targeting of
the antigen o¡ers new opportunities in prevention of toxo-
plasmosis.
2. Materials and methods
2.1. Volunteers and sample collection
Tear £uid was collected from eyes of four healthy adults (V1^V4),
using glass capillaries [4] (Assistent, Karl Hecht, Sondheim, Ger-
many). Tears were stored at 320‡C until use. This study was con-
ducted in accordance with the Declaration of Helsinki.
2.2. Parasites
T. gondii tachyzoites of the RH strain were propagated in vitro in
RK13 cells in RPMI medium with 3% fetal calf serum (Invitrogen).
Alternatively, RH strain tachyzoites were propagated in vivo in Swiss
mice. Parasites were ¢lter puri¢ed using ¢lters with a pore size of 3 Wm
supplemented with a pre-¢lter (Millipore). Following two washes with
phosphate-bu¡ered saline (PBS, pH 7.4), parasites were resuspended
in PBS containing protease inhibitors (Complete EDTA free, Roche)
and kept at 320‡C until use. Following freeze/thawing, parasite sus-
pensions were sonicated on ice (8U15 s, 30 kHz microprobe, Soniprep
150, MSE, Loughborough, UK), and insoluble material was removed
by centrifugation (16 000Ug, 20 min, 4‡C). The water-soluble extract
of T. gondii parasites (lysate) was frozen in small aliquots.
2.3. Ammonium sulfate precipitation
Ammonium sulfate (AS) was added stepwise within 15 min to 10 ml
of Toxoplasma lysate to saturation percentages of 26, 38, 51, 64, 78,
and 100%. At each of the percentages, the suspension was gently
stirred for another 20 min. Following centrifugation for 20 min at
10 000Ug and 4‡C, supernatants were used for the next precipitation
step, while the pellet was dissolved in TE bu¡er (10 mM Tris pH 8,
1 mM EDTA) containing protease inhibitors. Ten Wl of each fraction
was loaded on a gel, size-fractionated, and subsequently blotted.
2.4. SDS^PAGE, Western blotting and detection of peroxidase-
conjugated antibodies
Procedures were performed as described earlier [3,5]. L-Mercapto-
ethanol (L-ME) was added to a ¢nal concentration of 5% prior to
electrophoresis. Following electrophoresis, protein preparations were
transferred to polyvinylidene di£uoride membranes (Millipore).
Bound antibodies were visualized by chemiluminescence and exposed
to X-ray ¢lm.
2.5. Mass spectrometry
The 49 kDa antigen, one of the few antigens in the pellet of the
100% AS fraction, was cut from the gel after staining and destaining
with bio-safe Coomassie stain (Bio-Rad) according to the manufac-
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turer’s instructions. For MALDI analysis, protein-containing gel sli-
ces were S-alkylated with iodoacetamide, digested with trypsin (Roche
Molecular Biochemicals, sequencing grade), and extracted according
to Shevchenko et al. [6]. Only peptides eluted with 20 mM NH4HCO3
were used in the analysis. After drying in a vacuum centrifuge, pep-
tides were dissolved in 10 Wl of a solution containing 1% formic acid
and 60% acetonitrile. Eluted peptides were mixed 1:1 (v/v) with a
solution containing 52 mM K-cyano-4-hydroxycinnamic acid (Sig-
ma-Aldrich Chemie BV) in 50% ethanol/50% acetonitrile. Prior to
dissolving, the K-cyano-4-hydroxycinnamic acid was washed brie£y
with acetone. The mixture was spotted on target and allowed to dry
at room temperature. Re£ectron matrix-assisted laser desorption ion-
ization time of £ight mass spectrometry (MALDI-TOF) spectra were
acquired on a Micromass Tof Spec HT (Wythenshawe, UK). The
resulting peptide spectra were used to search ABCC Non-Redundant
Protein Database release 20000301 (Advanced Biomedical Computing
Center, Frederick, MD, USA) (http://www-fbsc.ncifcrf.gov/). For fur-
ther MS-MS analysis, a few microliters of several peptide solutions
were concentrated on a C18 ZipTip (Millipore), eluted in 5 Wl 60%
acetonitrile/1% HCOOH and analyzed on a Micromass Q-TOF mass
spectrometer. Low-energy collision-induced dissociation (CID) experi-
ments were performed using argon as a collision gas. Homology
searches with fragmented peptides were performed using the BLASTx




The following primers were based on T. gondii EST dbEST ID#
1374495: PDI 1, 5P-CGGCTTCGTCTTGCTTCTC-3P (antisense
(as)); PDI 3, 5P-AACGTGCCAAGAAACTCCG-3P (sense (s)); PDI
5, 5P-CGGGACAGGCTCAGACTTC-3P (as); PDI 6, 5PTAGCAGC-
GTCCTTCAGGGA-3P (as). Primers used to amplify full-length
cDNA and genomic sequence: PDI 23, 5P-GAGACATATGGAGG-
AGGAAGCTGTGACT-3P (s); PDI 24 5P-AGACTCGAGTTACAG-
TTCTTCACCCTT-3P (as). Other primers: PDI 7, 5P-GAGACCCG-
GGTTTTTTTTTTTTTTTV-3P (with V=A, C or G); PDI 11, 5P-
TAAGGTCGATGCCACCAG-3P (s); PDI 22, 5P-GAGACCATGG-
GTCAAGGTTGTCGTCGGA-3P (s).
2.7. Cloning of PCR products, RT, and RACE
PCR products were either ligated into the pGEM-T Easy cloning
vector as described by the manufacturer (Promega), or digested and
ligated into expression vector pRP261, a derivative of vector pGEX-
3X (Amersham Biosciences).
Rapid ampli¢cation of unknown cDNA ends (RACE) was per-
formed as described [7], with minor modi¢cations. RNA was ex-
tracted from T. gondii tachyzoites using RNAzol reagent (Campro
Scienti¢c, Hilversum, The Netherlands). cDNA was synthesized using
1 Wg RNA and Superscript II reverse transcriptase (RT) (Invitrogen),
RNA was subsequently removed by RNase H treatment (Promega,
Leiden, The Netherlands). For 5P RACE, primer PDI 1 was used for
¢rst strand synthesis, followed by dA tailing by terminal deoxynucleo-
tidyltransferase (Invitrogen). Second strand cDNA was synthesized
using primer PDI 7 (s). Semi-nested PCR reactions were carried out
with primers PDI 7 (s) and PDI 6. Primers PDI 3 and PDI 7 (as) were
used for 3P RACE. Four independent clones from both the 5P and 3P
RACE procedure were sequenced, using pGEM-T Easy vector-speci¢c
primers (SP6 and -40) and PDI 7, PDI 11, PDI 1 and PDI 6.
2.8. Sequencing and analysis of nucleotide and protein sequences
All sequencing was performed on an Applied Biosystems Prism 310
dye terminator £uorescent-based genetic analyzer (PE Applied Bio-
systems, Warrington, UK). Homology searches were done using the
BLASTx program with default settings. Multiple sequence alignments
were performed using the CLUSTAL W program with default settings
(at http://www.ebi.ac.uk/clustalw/). Splice sites in genomic sequences
were predicted using the Fgenesm program (version FGENES-M
1.5.0, http://genomic.sanger.ac.uk/gf/gf.shtml). Signal P program was
used for analysis of potential signal peptide cleavage sites (version 1.1,
at http://www.cbs.dtu.dk/services/SignalP/).
2.9. Northern blotting, Southern blotting and autoradiography
These were performed as described earlier [8], with minor modi¢-
cations.
Northern blots containing 2 and 10 Wg size-separated T. gondii
RNA were incubated with [K-32P]dCTP-labeled probes speci¢c for
SAG1 (V1 kb fragment) and the protein disul¢de isomerase (PDI)
EST (V300 bp fragment).
2.10. Construction of the PDI expression vectors
To release the fragment encoding the 5P part of PDI, the 5PRACE-
pGEM-T Easy construct was digested with BstXI (Invitrogen), fol-
lowed by deletion of the 3P overhang using Klenow enzyme (Roche)
and digestion with Bsu36 (New England Biolabs). The 3PRACE-
pGEM-T Easy construct was digested with NcoI, its 5P overhang ¢lled
by Klenow, followed by digestion with Bsu36. The fragment encoding
5P PDI was ligated into this digested vector, resulting in a full-length
PDI-pGEM-T Easy construct. Upon digestion of this latter construct
with NcoI and SpeI, the resulting fragment with the PDI open reading
frame was transferred to pRP261. The 3P RACE-pGEM-T Easy con-
struct was digested with MaeII (New England Biolabs) and Klenow
(Roche) ¢lled. Following puri¢cation, the 3P RACE product was re-
leased by digestion with SpeI. This fragment was ligated into pRP261,
previously digested with SmaI and SpeI, and will be referred to as
3P rPDI.
2.11. Expression, puri¢cation, and detection of recombinant proteins
coupled to GST
All proteins were expressed in Escherichia coli strain BL21 accord-
ing to standard procedures [8]. Expression was induced by adding
isopropyl-L-D-thiogalactopyranoside (1 mM) at 30‡C. Glutathione
S-transferase (GST), with or without fusion protein, was puri¢ed us-
ing glutathione Sepharose 4B beads according to the manufacturer’s
instructions (Amersham Biosciences). For protein gels, beads were
directly solubilized in sample bu¡er. The amount of each recombinant
protein used for immunoblots was normalized based on intensity of
Coomassie staining on gel and staining with anti-GST antibody on
immunoblot. For the detection of GST and GST-coupled proteins,
antibodies were removed by incubation of blots in erase bu¡er (62.5
mM Tris pH 6.8, 100 mM L-ME, 2% w/v SDS) for 1 h at 70‡C.
Subsequently, blots were blocked for 1 h and incubated with anti-
GST-peroxidase (diluted 10 000U, Sigma).
2.12. PDI speci¢c antibodies
A rabbit previously selected for being non-responsive on a T. gondii
lysate immunoblot was immunized once s.c. and i.m. with 500 Wg of
the puri¢ed PDI^GST fusion protein, using Specol (ID-DLO, Lely-
stad, The Netherlands) as adjuvant. Plasma was stored at 320‡C until
use.
3. Results and discussion
3.1. Fractional precipitation and mass spectrometry
The 49 kDa antigen was partially puri¢ed from an extract
of T. gondii by AS precipitation. Western blot analysis of the
AS fractions showed that the 49 kDa antigen precipitated
most e⁄ciently at 100% saturation with only few other
T. gondii proteins, as these had been precipitated at 78% sat-
uration (see Fig. 1A). To exclude the possibility that the major
band at 49 kDa in this fraction consisted of multiple proteins,
a gel fragment containing this band was loaded onto a protein
gel with a di¡erent acrylamide/bisacrylamide ratio. Coomassie
staining revealed a single band that was sliced out and used
for mass spectrometric analysis.
Upon digestion with trypsin, resulting peptides were ana-
lyzed by MALDI-TOF. Because the peptide mass ¢ngerprint
did not identify the 49 kDa protein, selected peptides were
analyzed by collision-induced dissociation on an ESI-Q-
TOF. Some of the peptides matched dbEST entry ID#
1374495 (Fig. 1B,E). This EST of 300 bp encodes part
of PDI of T. gondii, a protein not yet described for this para-
site.
PDIs belong to the superfamily of thioredoxins (Trx), a
group of oxidoreductases characterized by one or more thio-
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redoxin-like boxes with a CXXC motif [9]. One of the main
functions of oxidoreductase is facilitating de novo formation
of disul¢de bridges between cysteines (oxidation), and/or re-
arranging existing disul¢de bridges (isomerization). Besides
acting as oxidoreductase, PDI also assists in protein folding,
functions as a chaperone, and forms a subunit of prolyl-4-
hydroxylase and triacylglycerol transfer proteins [9].
All major surface antigens of T. gondii, SAG1 and related
proteins, have high numbers of intramolecular disul¢de bonds
[10] which might explain the high expression level of PDI
observed in T. gondii (see below).
3.2. Characterization of the cDNA encoding T. gondii PDI
The full-length cDNA sequence of PDI was obtained by
5P and 3P RACE using primers based on dbEST entry ID
#1374495. This resulted in cDNA products of approximately
1100 bp (5P RACE) and 600 bp (3P RACE). Northern blot
analysis of total T. gondii RNA with a PDI cDNA fragment
showed a single transcript of about 2 kb (Fig. 1C), abundantly
present (compare with signal of the SAG1 message) and
roughly matching the combined length of the 5P and 3P
RACE products.
Sequence analysis showed that Toxoplasma PDI contained
Fig. 1. Identi¢cation and characterization of the 49 kDa antigen of T. gondii. A: AS was added to saturation percentages indicated above the
lanes and precipitated proteins were analyzed. Ponceau red staining patterns on blots (PR) are shown, as well as IgA staining patterns of strips
incubated with tear sample V1 (IB). Tear samples of volunteer V1 were used for this experiment, because they predominantly contained IgA
antibodies for the 49 kDa antigen. B: A triply protonated tryptic peptide of m/z 580.6 was fragmented from which a deconvoluted MS-MS
spectrum with a partial sequence tag, ISQFFDDVEA (569.3), was constructed. This tag was used to screen databases and matched with dbEST
entry ID# 1374495, an EST of 300 bp identi¢ed as part of the message encoding T. gondii PDI. X-axis: m/z, y-axis: relative intensity.
C: Northern blots containing size-separated T. gondii RNA were incubated with labelled probes speci¢c for SAG1 and the PDI EST. The ribo-
somal RNA bands of T. gondii run at V3400 (28S) and V1850 (18S) nt, while SAG1 mRNA is about 1500 nt [18]. Shown are the lanes rep-
resenting 10 Wg (SAG1) and 2 Wg RNA (PDI). Blots were exposed to ¢lm for 5 h. PDI mRNA is estimated to be about 2000 nt in length.
D: T. gondii DNA was digested with the restriction enzymes indicated above each lane. Southern blots were probed with a labelled PDI
cDNA fragment of 1350 bp. EcoRI digestion resulted in three fragments. Since PDI cDNA has two EcoRI sites, this pattern indicates a single
copy gene for PDI. E: Positions of introns in genes encoding PDI of Plasmodium falciparum and T. gondii are indicated by arrowheads. The
position in the Trx domain of the ¢rst intron in the coding sequence is identical to the single intron of P. falciparum. T. gondii is unique in
having a second intron at nt position 815. Light gray boxes represent Trx-like domains with CGHC motif, while a Trx-like domain with
CGYC motif at T. gondii aa positions 380^383 is indicated by a dark gray box. Recombinant proteins were expressed as GST fusion proteins.
The position of the peptide identi¢ed by mass spectrometry is given.
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the two Trx-like domains with active site sequence motif
CXXC characteristic for PDIs (indicated in Fig. 1E; accession
number AJ306291). Twenty-eight tryptic peptide peaks
present in the MALDI spectrum, including all predominant
peaks, matched the sequence obtained, yielding a sequence
coverage of 60%, con¢rming the 49 kDa protein as PDI.
T. gondii PDI di¡ers from all other known eukaryotic PDI
sequences in an amino acid substitution of the consensus his-
tidine (H) by a tyrosine (Y) in the C-terminal Trx-like do-
main. This HCY substitution was con¢rmed by sequencing
DNA from two di¡erent sources of T. gondii RH strains (data
not shown). In addition to Trx-like domains other functional
elements were predicted (see Fig. 1E), including a hydropho-
bic N-terminal signal sequence of 25 amino acids and a
C-terminal ER retention signal (GEEL).
The replacement of H by Y in one of the Toxoplasma
CXXC boxes is unique for eukaryotic PDIs described so
far. It is not likely to a¡ect the oxidoreductase function of
PDI. Besides being a neutral substitution, it is not unique to
Trx-like proteins in general, as one of the oxidoreductases of
E. coli, DsbC, also has Y in its CXXC box. However, com-
pared with DsbA, an oxidoreductase containing a ‘classic’
box, the function of DsbC is shifted towards isomerization
[11], so this might hold true for PDI of Toxoplasma.
Based on amino acid similarities, PDI of Toxoplasma most
closely resembles PDI of other members of the family of pro-
tozoan parasites like Plasmodium falciparum [12] and, some-
what less, Cryptosporidium parvum [13]. For alignments of
T. gondii PDI with closely related PDIs and associated fea-
tures, see supplemental ¢gure (http://www.elsevier.com/PII/
S0014579302029113).
3.3. Characterization of the genomic sequence encoding
T. gondii PDI
Analysis of a genomic fragment containing the complete
coding sequence of T. gondii PDI (accession number
AJ312317) showed the presence of two introns at bp positions
303 and 815 (Fig. 1E). The position in the Trx domain of the
¢rst intron in the coding sequence is identical to the single
intron of P. falciparum [12], the second intron is unique for
T. gondii. The genomic sequence encoding PDI of C. parvum
does not contain introns (see accession number U48261).
Southern blotting demonstrated a major fragment of approx-
imately 3 kb with EcoRI-digested chromosomal T. gondii
DNA (Fig. 1D) indicating a single locus for PDI in the
T. gondii genome.
3.4. Recognition of recombinant PDI by IgA in human tears
Full-length T. gondii PDI and its C-terminal part were ex-
pressed as GST fusion protein (Fig. 1E, rPDI and 3PrPDI,
respectively) in E. coli, puri¢ed and blotted. Both recombinant
PDI proteins were recognized by IgA antibodies in tears of
individuals known to have anti-49 kDa antibodies (Fig. 2A).
This recognition was not due to the GST part of the recombi-
nant protein as none of the volunteers had IgA antibodies
recognizing GST protein alone (see Fig. 2A, second panel).
Furthermore, rabbits challenged with recombinant PDI gen-
erate IgG antibodies reacting with the 49 kDa antigen, now
identi¢ed as PDI, on a T. gondii lysate blot (Fig. 2B).
As mentioned, PDI acts in the endoplasmic reticulum (ER).
However, the binding of PDI-speci¢c IgA antibodies to the
exterior of parasites clearly demonstrated the presence of PDI
on the surface [3]. There are examples of an extracellular
location of PDI, despite the presence of a carboxy-terminal
ER retention signal, e.g. on the surface of lymphocytes, in-
volved in adhesion of human immunode¢ciency virus [14],
and on the surface of platelets, mediating adhesion to integrin
[15]. It is possible that T. gondii PDI exits the ER bound to its
targets (e.g. SAG1 and related proteins, TgAma-1 [16,17])
functioning as a chaperone for these membrane proteins. To-
gether with proteins known to be involved in host cell adhe-
sion like SAG3 and TgAma-1 [16,17], PDI may also partic-
ipate in adhesion to host cells during the initial phase of
infection. Although PDIs of protozoan parasites resemble
their human equivalents, PDI of P. falciparum is selectively
targeted by compounds inhibiting growth of Plasmodium [12].
These compounds are screened for anti-malarial capacity, and
may also be of use in treatment of toxoplasmosis, especially in
the light of a possible adhesion function for PDI.
With respect to its function, PDI can be regarded as a
conserved protein. This suggests that these anti-T. gondii
PDI antibodies constitute part of the natural antibody mem-
Fig. 2. Recognition of recombinant and native PDI by IgA in tears
and immune serum. A: IgA antibodies in diluted tear samples of
volunteers were incubated with blot strips containing either soluble
T. gondii lysate proteins (Lysate), puri¢ed GST (GST, V28 kDa)
protein, GST coupled to 3P part of PDI (3P rPDI, V45 kDa) and
full-length PDI (rPDI, V77 kDa). Positions of native PDI (V49
kDa) on the Lysate strips, and recombinant proteins are marked
(s ). IgA in tears recognized rPDI and 3PrPDI. Two exposures are
shown (10 and 30 min). The anti-GST staining patterns were ob-
tained after GST and 3PrPDI containing immunoblot strips were
‘erased’. Vol. No. indicates volunteer number 1 to 4. Tear samples
were diluted 200U. B: The antibody speci¢cally generated against
recombinant PDI stained a 49 kDa antigen on lysate blot. [+] indi-
cates post-immune serum following immunization with rPDI and
[3] pre-immune serum. Rabbit serum was diluted 20 000U.
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ory repertoire of humans, which might have evolved to cope
with co-existing protozoan parasites. To con¢rm that these
anti-PDI antibodies are natural antibodies, experiments are
performed to characterize the regions on PDI they recognize.
Other mucosal sites will be analyzed to determine whether
these antibodies are unique for the lacrimal gland or are a
general characteristic of the common mucosal immune sys-
tem.
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